A clinical trial in the U.K. shows a significant reduction in hospital readmission.
Whether telemonitoring confers benefit after hospital discharge in patients with acute coronary syndrome (ACS) is unclear. To examine this issue, researchers conducted an open-label trial among 337 patients with ACS who underwent percutaneous coronary intervention at a single institution. At hospital discharge, participants were randomized to patient-initiated telemonitoring or routine care for 6 months.
The telemonitoring group received a 12-lead electrocardiogram machine, automated blood pressure monitor, and pulse oximeter, which patients used when experiencing cardiac symptoms. Monitoring results were automatically transmitted to trial staff and passed along to a cardiologist, who would conduct a remote clinical assessment of the patient…
Reviewing Author
DisclosuresGrant/Research SupportBrigham and Women’s Hospital; American Heart Association and VIVA Physicians
Editorial BoardsThrombosis Research; Thrombosis and Haemostasis; Journal of the American College of Cardiology
Leadership Positions in Professional SocietiesSociety for Vascular Medicine (Research, Quality, and Publications Committee member); International Society on Thrombosis and Haemostasis
DisclosuresGrant/Research SupportBrigham and Women’s Hospital; American Heart Association and VIVA Physicians
Editorial BoardsThrombosis Research; Thrombosis and Haemostasis; Journal of the American College of Cardiology
Leadership Positions in Professional SocietiesSociety for Vascular Medicine (Research, Quality, and Publications Committee member); International Society on Thrombosis and Haemostasis